A potential role for colony-stimulating factor 1 in the genesis of the early endometriotic lesion

Fertility and Sterility

Volumn 93, Issue 1, 2010, Pages 251-256

  Jensen, Jani R ^a,b   Witz, Craig A ^a,c   Schenken, Robert S ^a   Tekmal, Rajeshwar R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MAYO CLINIC   (United States)

^c Houston Fertility Institute   (United States)

Author keywords

animal model; colony stimulating factor 1; CSF 1; Endometriosis; imatinib

Indexed keywords

C FMS; COLONY STIMULATING FACTOR 1; CYTOKINE RECEPTOR; IMATINIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CANCER GRAFT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; FEMALE; HISTOPATHOLOGY; HOMOZYGOSITY; MESOTHELIUM CELL; MOUSE; MUTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTERACTION; RECIPIENT;

ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL; FEMALE; HOMOZYGOTE; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; TIME FACTORS;

EID: 72749113314     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.09.050     Document Type: Article

References (37)

1. Eskenazi B., and Warner M.L. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24 (1997) 235-258
2. Sampson J. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14 (1927) 422-469
3. Halme J., Hammond M.G., Hulka J.F., Raj S.G., and Talbert L.M. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 64 (1984) 151-154
4. Liu D.T., and Hitchcock A. Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology. BJOG 93 (1986) 859-862
5. Keettel W.C., and Stein R.J. The viability of the cast-off menstrual endometrium. Am J Obstet Gynecol 61 (1951) 440-442
6. Mungyer G., Willemsen W.N., Rolland R., Vemer H.M., Ramaekers F.C., Jap P.H., et al. Cell of the mucous membrane of the female genital tract in culture: a comparative study with regard to the histogenesis of endometriosis. In Vitro Cell Dev Biol 23 (1987) 111-117
7. Ridley J.H., and Edwards I.K. Experimental endometriosis in the human. Am J Obstet Gynecol 76 (1958) 783-790
8. D'Hooghe T.M., Bambra C.S., Raeymaekers B.M., DeJonge I., Lauweryns J.M., and Koninckx P.R. Intrapelvic injection of menstrual endometrium causes endometriosis in baboons (Papio cynocephalus and Papio anubis). Am J Obstet Gynecol 173 (1995) 125-134
9. TeLinde R.W., and Scott R.B. Experimental endometriosis. Am J Obstet Gynecol 60 (1950) 1147-1173
10. Witz C.A., Allsup K.T., Montoya-Rodriguez I.A., Vaughn S.L., Centonze V.E., and Schenken R.S. Culture of menstrual endometrium with peritoneal explants and mesothelial monolayers confirms attachment to intact mesothelial cells. Hum Reprod 17 (2002) 2832-2838
11. Witz C.A., Cho S., Centonze V.E., Montoya-Rodriguez I.A., and Schenken R.S. Time series analysis of transmesothelial invasion by endometrial stromal and epithelial cells using three-dimensional confocal microscopy. Fertil Steril 79 Suppl 1 (2003) 770-778
12. Nair A.S., Lucidi R.S., Kirchner A.J., Nair H.B., Tekmal R.R., and Witz C.A. Endometrial cell binding to mesothelial cells enhances invasion of endometrial cells in a 3-dimensional model of human peritoneum. Fertil Steril 86 Suppl 1 (2006) S262
13. Witz C.A., Lucidi R.S., Centonze V.E., Liu Y.G., Jones J., and Tekmal R.R. Characterization of a novel three-dimensional model of the early endometriotic lesion. Fertil Steril 82 Suppl 2 (2004) S72
14. Witz C.A., Montoya-Rodriguez I.A., Centonze V.E., and Schenken R.S. Menstrual endometrium and individual endometrial stromal and epithelial cells are unique in their ability to adhere to and invade peritoneal mesothelium. [abstract]. Fertil Steril 78 Suppl 1 (2002) S199
15. Witz C.A., Montoya-Rodriguez I.A., and Schenken R.S. Whole explants of peritoneum and endometrium: a novel model of the early endometriosis lesion. Fertil Steril 71 (1999) 56-60
16. Mettler L., Schmutzler A.G., Koch K., Schollmeyer T., and Salmassi A. Identification of the M-CSF receptor in endometriosis by immunohistochemistry and RT-PCR. Am J Reprod Immunol 52 (2004) 298-305
17. Baiocchi G., Kavanagh J.J., Talpaz M., Wharton J.T., Gutterman J.U., and Kurzrock R. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer 67 (1991) 990-996
18. Wanichkul T., Han S., Huang R., and Sidell N. Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells. Fertil Steril 79 Suppl 1 (2003) 763-769
19. Griffith J.S.., Binkley P.A., Kirma N.R., Witz C.A., Schenken R.S., and Tekmal R.R. Imatanib alters expression of endometrial stromal cell signaling genes involved in cell proliferation and metastasis. [abstract]. Fert Stert 90 (2008) S145. http://www.fertstert.org/issues/contents?issue_key=S0015-0282(08)X0012-3 Available online at: http://www.fertstert.org/issues/contents?issue_key=S0015-0282(08)X0012-3
20. Nair A.S., Nair H.B., Lucidi R.S., Kirchner A.J., Schenken R.S., Tekmal R.R., et al. Modeling the early endometriotic lesion: mesothelium-endometrial cell co-culture increases endometrial invasion and alters mesothelial and endometrial gene transcription. Fertil Steril 90 (2008) 1487-1495
21. Dewar A.L., Cambareri A.C., Zannettino A.C.W., Miller B.L., Doherty K.V., Hughes T.P., et al. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 105 (2005) 3127-3132
22. Dewar A.L., Zannettino A.C.W., Hughes T.P., and Lyons A.B. Inhibition of c-fms by imatinib: expanding the spectrum of treatment. Cell Cycle 4 (2005) 851-853
23. Taylor J.R., Brownlow N., Domin J., and Dibb N.J. FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance. Oncogene 25 (2006) 147-151
24. Hirata T., Osuga Y., Yoshino O., Hirota Y., Harada M., Takemura Y., et al. Development of an experimental model of endometriosis using mice that ubiquitously express green fluorescent protein. Human Reprod 20 (2005) 2092-2096
25. Somigliana E., Vigano P., Rossi G., Carinelli S., Vignali M., and Panina-Bordignon P. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Human Reprod 14 (1999) 2944-2950
26. Wolff N.C., and Ilaria R.L. Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571. Blood 98 (2001) 2808-2816
27. Aono Y., Nishioka Y., Inayama M., Ugai M., Kishi J., Uehara H., et al. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Resp Crit Care Med 171 (2005) 1279-1285
28. Sinai P., Berg R.E., Haynie J.M., Egorin M.J., Ilaria R.L., and Forman J. Imatinib mesylate inhibits antigen-specific memory CD8 T cell responses in vivo. J Immunol 178 (2007) 2028-2037
29. Aoki D., Katsuki Y., Shimizu A., Kakinuma E., and Nozawa S. Successful heterotransplantation of human endometrium in SCID mice. Obstet Gynecol 83 (1994) 220-228
30. Nisolle M., Casanas-Roux F., and Donnez J. Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice. Fertil Steril 74 (2000) 306-312
31. Lu X.E., Ning W.X., Dong M.Y., Liu A.X., Jin F., and Huang H.F. Vascular endothelial growth factor and matrix metalloproteinase-2 expedite formation of endometriosis in the early stage ICR mouse model. Fertil Steril 86 Suppl 3 (2006) 1175-1181
32. Matsuzaki S., Canis M., Darcha C., Dechelotte P.J., Pouly J.L., and Mage G. Effects of a protein kinase C inhibitor in the initial development of ectopic implants in a syngeneic mouse model of endometriosis. Fertil Steril 89 (2008) 206-211
33. Kyama C.M., Overbergh L., Debrock S., Valckx D., Vander Perre S., Meuleman C., et al. Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis. Fertil Steril 85 (2006) 1667-1675
34. Savage D.G., and Antman K.H. Imatinib mesylate-a new oral targeted therapy. N Engl J Med 346 (2002) 683-693
35. Investigators brochure. STI571 (formerly CGP57148B) and data on file (2004), Novartis Pharma AG, Basel, Switzerland
36. Yilmaz M., Demirhan O., Kucukosmanoglu E., Pehlivan M., Okan V., Balat O., et al. Pregnancy in patients with chronic myeloid leukemia treated with imatinib. Leuk Lymphoma 48 (2007) 2454-2456
37. Russell M.A., Carpenter M.W., Akhtar M.S., Lagattuta T.F., and Egorin M.J. Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk. J Perinatol 27 (2007) 241-243